In this video interview, Jonathan W. Goldman, MD, a health sciences clinical instructor in the Department of Medicine at the Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics Program at UCLA, discusses data regarding the use of immunotherapy for oncogene-driven non-small cell lung cancer (NSCLC), specifically cases with EGFR mutations or ALK fusions.

Learn more by clicking here.